All Posts By

Smartkarma Daily Briefs

Daily Brief Macro: China’s Economic Plan: THE MOVING PARTS AND WHAT TO WATCH and more

By | Daily Briefs, Macro

In today’s briefing:

  • China’s Economic Plan: THE MOVING PARTS AND WHAT TO WATCH
  • US Treasury Market Questions Fed’s Prospective Policy Path
  • Near-Term Volatility Ahead, But Don’t Fret
  • A Time for Bullish Patience


China’s Economic Plan: THE MOVING PARTS AND WHAT TO WATCH

By David Mudd

  • China is not in a 2015 boom/bust period with households under-invested in the stock market.
  • It is now time for China to begin fiscal stimulus as discussed at the MOF meeting over the weekend.  Central government will relieve local governments’ hidden debt through debt swaps.
  • PBOC and MOF will closely watch interest rates and government yields as they roll out fiscal measures.  CNY levels will also be considered in future policy decisions.

US Treasury Market Questions Fed’s Prospective Policy Path

By Said Desaque

  • The Fed’s policy pivot to concentrate on the labour market reflects the priorities of politicians who view full employment as the more important mandate compared to price stability.
  • Doubts about the wisdom of the Fed’s aggressive policy rate reduction have increased since the release of the September Employment Situation report. Bond investors have demanded a higher term premium.
  • Surveys on household and business optimism are sending worrying signals.  Fed credibility will face communication challenges as long as forward guidance indicates easier policy but economic outlook risks remain balanced.

Near-Term Volatility Ahead, But Don’t Fret

By Cam Hui

  • Volatility in economic data feeds through to bond market volatility because of the Fed’s increasing focus on data dependency.
  • Wobbles in earnings estimate growth at the start of Q3 earnings season is leading to uncertainty in stock prices.
  • We believe these sources of volatility will resolve themselves in a benign manner.

A Time for Bullish Patience

By Cam Hui

  • Stock market internals are call for near-term caution but intermediate-term bullishness.
  • Election uncertainty, along with cross-currents such as the stronger-than-expected CPI report is creating market volatility.
  • But market internals reveal a strong bull trend and a near-oversold condition.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Fuji Soft Inc, Tokyo Metro, TSE Tokyo Price Index TOPIX, Shionogi & Co and more

By | Daily Briefs, Japan

In today’s briefing:

  • Bain Bids Bigger, Goes Hard on Fuji Soft (9749); I’ve Got 🍿🍿🍿
  • Fuji Soft (9749 JP): Bain’s Better Late than Never Competing Offer
  • ECM Weekly (14th Oct 2024) – Tokyo Metro, Rigaku, Hyundai, China Res, Swiggy, USS, Akeso, Shiyue
  • After TSE’s Request, the Key Is Whether the Company Can Deliver While Investors Are Still Hopeful
  • Shionogi & Co (4507 JP): Performance to Improve in H2; Upcoming Drugs to Accelerate Growth


Bain Bids Bigger, Goes Hard on Fuji Soft (9749); I’ve Got 🍿🍿🍿

By Travis Lundy

  • As they had announced was their intention, Bain has made a binding offer for Fuji Soft Inc (9749 JP), bidding ¥9,450 against KKR’s ¥8,800. They aim to launch late October.  
  • There is no minimum and no maximum. The Founding Nozawa family had thrown their lot in with Bain not KKR and that 18.5% is tied up. 
  • There are conditions, and those are ALL-important. And I expect we see in the next week or so how coercive KKR’s “non-coercive” scheme change was. I’ve got 🍿🍿🍿.

Fuji Soft (9749 JP): Bain’s Better Late than Never Competing Offer

By Arun George

  • Bain’s pre-conditional tender offer for Fuji Soft Inc (9749 JP) is JPY9,450, a 7.4% premium to KKR’s JPY8,800 offer. There is no minimum or maximum acceptance condition.
  • The preconditions relate to regulatory approval (Vietnam) and Board recommendation. Bain’s offer is designed to bring KKR to the negotiating table to find a solution to privatisation. 
  • KKR can 1) do nothing, 2) work with Bain on a solution, or 3) engage in a price war to prevent the satisfaction of Bain’s Board recommendation precondition.

ECM Weekly (14th Oct 2024) – Tokyo Metro, Rigaku, Hyundai, China Res, Swiggy, USS, Akeso, Shiyue

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the live IPOs front, the two Japanese IPOs, Tokyo Metro (9023 JP) and Rigaku Holdings (268A JP) appeared attractively priced. The same couldn’t be said about Hyundai Motor India.
  • On the placements front, there were deals in Hong Kong, Japan and India. 

After TSE’s Request, the Key Is Whether the Company Can Deliver While Investors Are Still Hopeful

By Aki Matsumoto

  • There’s gap in timelines for results between many companies that started to incorporate the cost of capital into their management and investors who are looking for results in investment performance.
  • If this gap surfaces, investor expectations will be stripped away. Companies that determine that it will take a long time to achieve results can be expected to consider going private.
  • For a company to seek access to institutional investors, it must first produce results. The race is on to achieve results within limited timeframes and faster than other companies.

Shionogi & Co (4507 JP): Performance to Improve in H2; Upcoming Drugs to Accelerate Growth

By Tina Banerjee

  • Shionogi & Co (4507 JP) has reiterated FY25 guidance, indicating sequentially better financial performance in Q2FY25 as well as H2FY25. Overseas business and royalty income are on strong footing.
  • Shionogi has acquired the exclusive distribution rights for Quviviq in Japan. With better efficacy and safety profile, and sizable patient population, Quviviq should be a significant revenue contributor.
  • Shionogi submitted NDA in Japan for zuranolone, a treatment in development for major depressive disorder (MDD). Approval is expected in H1FY26.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: CAR Group , Bell Financial and more

By | Australia, Daily Briefs

In today’s briefing:

  • S&P/ASX Index Rebalance Preview (Dec 2024): Big Impact as Shorts Ramp Up
  • Bell Financial Group Ltd – Strong September quarter earnings drivers


S&P/ASX Index Rebalance Preview (Dec 2024): Big Impact as Shorts Ramp Up

By Brian Freitas

  • With three quarters of the review period complete, there could be one change for the S&P/ASX 50 Index and two changes for the S&P/ASX 200 (AS51 INDEX) in December. 
  • There are two stocks that could be deleted from global indexes in November and that could keep those names under pressure for the next few weeks.
  • Passive trackers will need to buy between 4-5x ADV in the forecast adds and sell between 2-8x ADV in the forecast deletes. Shorts have been building up in some names.

Bell Financial Group Ltd – Strong September quarter earnings drivers

By Research as a Service (RaaS)

  • RaaS has published an update report on diversified financials company Bell Financial Group (ASX:BFG) on the back of supportive September 2024 metrics including ECM league tables, ASX volumes and equity markets performance.
  • BFG is sitting fourth on the LSEG ECM league tables for the nine months to September 2024, raising $1.2b and on-track with RaaS forecasts (positive for Retail and Institutional).
  • The ASX200 closed 6.3% higher at the end of September 2024 relative to June 2024, above implied RaaS assumptions for the full-year and positive for the Portfolio Administration Services (PAS) business and overall investor confidence.ASX transaction volumes continue to recover from a weak CY23, up 32% for the September quarter and positive for the Retail and Technology & Platforms divisions.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: KraneShares CSI China Internet ETF, Microsoft Corp and more

By | Daily Briefs, United States

In today’s briefing:

  • China ETF Inflows & Implications: YTD Inflows Nearing US$150bn
  • Microsoft Eyes Strong Q1 FY2025 Earnings: Will AI Innovations Drive Performance?


China ETF Inflows & Implications: YTD Inflows Nearing US$150bn

By Brian Freitas

  • Nearly US$140bn has flowed into mainland China listed ETFs year to date and there have been big creations in the last few weeks as stocks have surged.
  • 97% of all inflows are in ETFs benchmarked to the CSI300, CSI1000, CSI500, SSE50, ChiNext and STAR50 indices. But over US$4bn has gone into other ETFs in the last week.
  • The large ETF inflows over the last few weeks has led to index rebalance strategies underperforming in China. But that should reverse from now to rebalance implementation.

Microsoft Eyes Strong Q1 FY2025 Earnings: Will AI Innovations Drive Performance?

By Uttkarsh Kohli

  • Microsoft is projected to report an EPS of $3.10 for Q1 FY2025, reflecting a year-over-year increase, highlighting consistent growth amid evolving market dynamics.
  • With a quarterly dividend increase of 10% and a $60 billion share repurchase program approved, Microsoft aims to enhance shareholder value while navigating competitive pressures.
  • Amid concerns of slowing AI adoption, analysts are divided on Microsoft’s outlook, balancing high expectations against rising expenses, especially with its significant investments in AI and cloud infrastructure.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Haitong Securities Co Ltd (H), Air China Ltd (H), Tencent, Akeso Biopharma Inc, Nameson Holdings, China Jinmao Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • Merger Arb Mondays (14 Oct) – Haitong/GJTA, GA Pack, Henlius, Canvest, Seven & I, Arcadium Lithium
  • Rebound in Int’l Demand & Benign Fuel Prices Could Support Recovery in Chinese Airlines’ Share Perf
  • Quiddity Leaderboard HS Internet & IT: Dec 24 Flow Expectations and Mar 25 Expected ADDs/DELs
  • Akeso Biopharma Placement – The Placing Price Is Not Cheap Despite Positive Business Progress
  • Nameson Holdings (1982 HK): 17% Dividend Yield Can Be Sustained and Improved Long-Term
  • Morning Views Asia: China Jinmao Holdings, Yuexiu Property



Rebound in Int’l Demand & Benign Fuel Prices Could Support Recovery in Chinese Airlines’ Share Perf

By Daniel Hellberg

  • By many metrics, Chinese airlines’ recent performance exceeds pre-Covid levels
  • Medium-Term, ongoing int’l recovery and benign fuel prices can boost margins
  • We believe the airlines could recoup weak relative performance vs Trip.com

Quiddity Leaderboard HS Internet & IT: Dec 24 Flow Expectations and Mar 25 Expected ADDs/DELs

By Janaghan Jeyakumar, CFA

  • The Hang Seng Internet & IT (HSIII) index represents the top 30 stocks related to internet and information technology businesses listed in Hong Kong (HKEX).
  • In this insight, we take a look at our capping flow expectations for the December 2024 index rebal event.
  • We have also presented our index change expectations for the next semiannual index review which will take place in March 2025.

Akeso Biopharma Placement – The Placing Price Is Not Cheap Despite Positive Business Progress

By Xinyao (Criss) Wang

  • HARMONi-2 results are impressive and the overall data is solid and reliable. The NMPA has approved NDA of ebronucimab and sNDA of cadonilimab. Akeso’s fundamentals have indeed undergone positive changes.
  • Akeso’s current market capitalization already partially reflects the positive expectation about the future successful FDA approval of AK112. In our view, the Placing Price is not cheap.
  • When the market value falls back to below RMB45 billion is a more comfortable valuation to buy Akeso, and below RMB35 billion market value provides a golden opportunity. 

Nameson Holdings (1982 HK): 17% Dividend Yield Can Be Sustained and Improved Long-Term

By Sameer Taneja


Morning Views Asia: China Jinmao Holdings, Yuexiu Property

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Fuji Soft Inc, Kina Securities Ltd, Korea Zinc, CAR Group , KraneShares CSI China Internet ETF, Haitong Securities Co Ltd (H), QuantumPharm and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Bain Bids Bigger, Goes Hard on Fuji Soft (9749); I’ve Got 🍿🍿🍿
  • Smartkarma Corporate Webinar | Kina Bank: Rapidly Growing Bank from Papua New Guinea
  • Korea Zinc: Latest Stockholder Record for Proration Risk
  • S&P/ASX Index Rebalance Preview (Dec 2024): Big Impact as Shorts Ramp Up
  • Korea Zinc Raises Share Buyback and Tender Offer Price to 890,000 Won
  • China ETF Inflows & Implications: YTD Inflows Nearing US$150bn
  • Merger Arb Mondays (14 Oct) – Haitong/GJTA, GA Pack, Henlius, Canvest, Seven & I, Arcadium Lithium
  • Fuji Soft (9749 JP): Bain’s Better Late than Never Competing Offer
  • China’s Economic Plan: THE MOVING PARTS AND WHAT TO WATCH
  • Quiddity Leaderboard Hang Seng Biotech Dec 24: Two Changes Expected + Capping Flows


Bain Bids Bigger, Goes Hard on Fuji Soft (9749); I’ve Got 🍿🍿🍿

By Travis Lundy

  • As they had announced was their intention, Bain has made a binding offer for Fuji Soft Inc (9749 JP), bidding ¥9,450 against KKR’s ¥8,800. They aim to launch late October.  
  • There is no minimum and no maximum. The Founding Nozawa family had thrown their lot in with Bain not KKR and that 18.5% is tied up. 
  • There are conditions, and those are ALL-important. And I expect we see in the next week or so how coercive KKR’s “non-coercive” scheme change was. I’ve got 🍿🍿🍿.

Smartkarma Corporate Webinar | Kina Bank: Rapidly Growing Bank from Papua New Guinea

By Smartkarma Research

For our next Corporate Webinar, we are glad to welcome Kina Bank’s executive management to Smartkarma. In the upcoming webinar, they will share a short company presentation after which, they will engage in a fireside chat with Smartkarma Insight Provider, Daniel Tabbush. The Corporate Webinar will include a live Q&A session.

The Corporate Webinar will be hosted on Tuesday, 15 October 2024, 17:00 SGT.

About Kina Bank

Kina Securities Limited (Kina Bank) was established in 1985 and is Papua New Guinea’s
second largest bank and financial services company. Kina Bank offers customers end-to-end financial solutions – from savings accounts to business loans, investments to mortgages, financial advice and investment management. It is also the largest wealth management business in PNG, with more than PGK11 billion of funds under management. As the country’s largest fund administrator, they administer accounts on behalf of more than 938,000 beneficiaries whose funds total almost PGK19 billion. Kina Bank is also the leading stockbroking company in PNG and is listed on the Australian Securities Exchange (ASX:KSL) and the PNG’s Stock Exchange (PNGX:KSL). 


Korea Zinc: Latest Stockholder Record for Proration Risk

By Sanghyun Park

  • If NPS and passive funds each tender half, it could hit 24%, pushing investors to consider both sides. The market’s eyeing a ratio of about MBK 3 to Choi 7.
  • This tight vote could drag out the event longer than expected, and MBK might scoop up more shares if they miss their minimum target.
  • MBK will likely go for open market buys against Korea Zinc’s buyback. Consider tendering to MBK Monday and spread trading futures, or push Korea Zinc to raise their buyback offer.

S&P/ASX Index Rebalance Preview (Dec 2024): Big Impact as Shorts Ramp Up

By Brian Freitas

  • With three quarters of the review period complete, there could be one change for the S&P/ASX 50 Index and two changes for the S&P/ASX 200 (AS51 INDEX) in December. 
  • There are two stocks that could be deleted from global indexes in November and that could keep those names under pressure for the next few weeks.
  • Passive trackers will need to buy between 4-5x ADV in the forecast adds and sell between 2-8x ADV in the forecast deletes. Shorts have been building up in some names.

Korea Zinc Raises Share Buyback and Tender Offer Price to 890,000 Won

By Douglas Kim

  • Korea Zinc raised the share buyback and tender offer price from 830,000 won to 890,000 won. Korea Zinc’s share price closed up by only 0.6% today to 794,000 won. 
  • As a result, the amount of capital involved in this share buyback and tender offer would increase from 2.7 trillion won to 3.2 trillion won.
  • Despite higher share buyback/tender offer of Korea Zinc by Choi family, we believe that this fight for the control of Korea Zinc is increasingly in favor of MBK/Jang family.

China ETF Inflows & Implications: YTD Inflows Nearing US$150bn

By Brian Freitas

  • Nearly US$140bn has flowed into mainland China listed ETFs year to date and there have been big creations in the last few weeks as stocks have surged.
  • 97% of all inflows are in ETFs benchmarked to the CSI300, CSI1000, CSI500, SSE50, ChiNext and STAR50 indices. But over US$4bn has gone into other ETFs in the last week.
  • The large ETF inflows over the last few weeks has led to index rebalance strategies underperforming in China. But that should reverse from now to rebalance implementation.


Fuji Soft (9749 JP): Bain’s Better Late than Never Competing Offer

By Arun George

  • Bain’s pre-conditional tender offer for Fuji Soft Inc (9749 JP) is JPY9,450, a 7.4% premium to KKR’s JPY8,800 offer. There is no minimum or maximum acceptance condition.
  • The preconditions relate to regulatory approval (Vietnam) and Board recommendation. Bain’s offer is designed to bring KKR to the negotiating table to find a solution to privatisation. 
  • KKR can 1) do nothing, 2) work with Bain on a solution, or 3) engage in a price war to prevent the satisfaction of Bain’s Board recommendation precondition.

China’s Economic Plan: THE MOVING PARTS AND WHAT TO WATCH

By David Mudd

  • China is not in a 2015 boom/bust period with households under-invested in the stock market.
  • It is now time for China to begin fiscal stimulus as discussed at the MOF meeting over the weekend.  Central government will relieve local governments’ hidden debt through debt swaps.
  • PBOC and MOF will closely watch interest rates and government yields as they roll out fiscal measures.  CNY levels will also be considered in future policy decisions.

Quiddity Leaderboard Hang Seng Biotech Dec 24: Two Changes Expected + Capping Flows

By Janaghan Jeyakumar, CFA

  • The HS HK-Listed Biotech Index (“Hang Seng Biotech Index”) represents the 50 largest biotech companies listed in Hong Kong (HKEX).
  • In this insight, we take a look at the final rankings of potential ADDs/DELs and our capping flow expectations for the December 2024 index rebal event.
  • We expect two changes for the HSHKBIO index in December 2024. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Industrials: Tokyo Metro, Azul SA, Ocean Wilsons Holdings and more

By | Daily Briefs, Industrials

In today’s briefing:

  • ECM Weekly (14th Oct 2024) – Tokyo Metro, Rigaku, Hyundai, China Res, Swiggy, USS, Akeso, Shiyue
  • Brazilian Airlines – Liability Management Even More Crucial Following BRL Weakness
  • Ocean Wilsons Holdings – Confirmation of interest in Wilson Sons holding


ECM Weekly (14th Oct 2024) – Tokyo Metro, Rigaku, Hyundai, China Res, Swiggy, USS, Akeso, Shiyue

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the live IPOs front, the two Japanese IPOs, Tokyo Metro (9023 JP) and Rigaku Holdings (268A JP) appeared attractively priced. The same couldn’t be said about Hyundai Motor India.
  • On the placements front, there were deals in Hong Kong, Japan and India. 

Brazilian Airlines – Liability Management Even More Crucial Following BRL Weakness

By Neil Glynn

  • Azul and GOL running with liability positions over double LATAM – convergence required to ensure financial sustainability.
  • Azul’s USD-denominated liabilities continue to weigh heavily, suggesting profitability and full balance sheet clean up distant prospects despite lessor re-negotiations.
  • GOL’s Chapter 11 process needs to focus on balance sheet recalibration – BRL weakness may require recalibration.

Ocean Wilsons Holdings – Confirmation of interest in Wilson Sons holding

By Edison Investment Research

Ocean Wilsons Holdings’ (OCN’s) H124 results showed good growth, reflecting a strong performance from Wilson Sons and a positive performance from the investment portfolio (OWIL). While the strategic review remains ongoing, in August the company announced that it is in discussions with I Squared that may or may not lead to an offer for its holding in Wilson Sons (BOVESPA: PORT3). Despite the review and the potential for value realisation, OCN still trades at a c 40% discount to our valuation of 2,275p/share.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Tokyo Metro, Azul SA, Ocean Wilsons Holdings and more

By | Daily Briefs, Industrials

In today’s briefing:

  • ECM Weekly (14th Oct 2024) – Tokyo Metro, Rigaku, Hyundai, China Res, Swiggy, USS, Akeso, Shiyue
  • Brazilian Airlines – Liability Management Even More Crucial Following BRL Weakness
  • Ocean Wilsons Holdings – Confirmation of interest in Wilson Sons holding


ECM Weekly (14th Oct 2024) – Tokyo Metro, Rigaku, Hyundai, China Res, Swiggy, USS, Akeso, Shiyue

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the live IPOs front, the two Japanese IPOs, Tokyo Metro (9023 JP) and Rigaku Holdings (268A JP) appeared attractively priced. The same couldn’t be said about Hyundai Motor India.
  • On the placements front, there were deals in Hong Kong, Japan and India. 

Brazilian Airlines – Liability Management Even More Crucial Following BRL Weakness

By Neil Glynn

  • Azul and GOL running with liability positions over double LATAM – convergence required to ensure financial sustainability.
  • Azul’s USD-denominated liabilities continue to weigh heavily, suggesting profitability and full balance sheet clean up distant prospects despite lessor re-negotiations.
  • GOL’s Chapter 11 process needs to focus on balance sheet recalibration – BRL weakness may require recalibration.

Ocean Wilsons Holdings – Confirmation of interest in Wilson Sons holding

By Edison Investment Research

Ocean Wilsons Holdings’ (OCN’s) H124 results showed good growth, reflecting a strong performance from Wilson Sons and a positive performance from the investment portfolio (OWIL). While the strategic review remains ongoing, in August the company announced that it is in discussions with I Squared that may or may not lead to an offer for its holding in Wilson Sons (BOVESPA: PORT3). Despite the review and the potential for value realisation, OCN still trades at a c 40% discount to our valuation of 2,275p/share.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Air China Ltd (H), Hyundai Motor India , TSE Tokyo Price Index TOPIX, Nameson Holdings and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Rebound in Int’l Demand & Benign Fuel Prices Could Support Recovery in Chinese Airlines’ Share Perf
  • Hyundai Motor India IPO: Valuation Insights
  • After TSE’s Request, the Key Is Whether the Company Can Deliver While Investors Are Still Hopeful
  • Nameson Holdings (1982 HK): 17% Dividend Yield Can Be Sustained and Improved Long-Term


Rebound in Int’l Demand & Benign Fuel Prices Could Support Recovery in Chinese Airlines’ Share Perf

By Daniel Hellberg

  • By many metrics, Chinese airlines’ recent performance exceeds pre-Covid levels
  • Medium-Term, ongoing int’l recovery and benign fuel prices can boost margins
  • We believe the airlines could recoup weak relative performance vs Trip.com

Hyundai Motor India IPO: Valuation Insights

By Arun George


After TSE’s Request, the Key Is Whether the Company Can Deliver While Investors Are Still Hopeful

By Aki Matsumoto

  • There’s gap in timelines for results between many companies that started to incorporate the cost of capital into their management and investors who are looking for results in investment performance.
  • If this gap surfaces, investor expectations will be stripped away. Companies that determine that it will take a long time to achieve results can be expected to consider going private.
  • For a company to seek access to institutional investors, it must first produce results. The race is on to achieve results within limited timeframes and faster than other companies.

Nameson Holdings (1982 HK): 17% Dividend Yield Can Be Sustained and Improved Long-Term

By Sameer Taneja


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Haitong Securities Co Ltd (H), NIFTY Index, IP Group PLC, Bell Financial, China Jinmao Holdings and more

By | Daily Briefs, Financials

In today’s briefing:

  • Merger Arb Mondays (14 Oct) – Haitong/GJTA, GA Pack, Henlius, Canvest, Seven & I, Arcadium Lithium
  • EQD / NSE Vol Update / ++Vol-Of-Vol & Unstable Vol-Regime. Structural Changes Unfolding in Vol Mkts?
  • EQD | Long Nifty 50 Vs. Short Nikkei 225 – A Relative Value Option Strategy with a Kicker
  • IP Group – Record exit underpinning the NAV
  • Bell Financial Group Ltd – Strong September quarter earnings drivers
  • Morning Views Asia: China Jinmao Holdings, Yuexiu Property



EQD / NSE Vol Update / ++Vol-Of-Vol & Unstable Vol-Regime. Structural Changes Unfolding in Vol Mkts?

By Sankalp Singh

  • Options Markets expected risk sentiment to deteriorate further – IVs were elevated. But lack of RV follow through caused sharp markdowns, especially for short-dated contracts.  
  • Increased Vol-of-vol has triggered multiple switches in Vol Regime Model – currently in “High & Down” vol-state. Multiple state-switches indicative of unfolding structural changes in Vol Markets.
  • Smile looking overly compressed in Monthly & Quarterly contracts as OTM Strangles trade close to par with ATMs.

EQD | Long Nifty 50 Vs. Short Nikkei 225 – A Relative Value Option Strategy with a Kicker

By Gaudenz Schneider

  • This strategy exploits relative value in implied volatilities and combines it with a long Nifty 50 vs. short Nikkei 225 directional view over a period of two months.
  • The strategy performs well if the Nifty 50 rises and outperforms the Nikkei 225. If both indices decline, neither profit nor loss is incurred.
  • Leverage increases both the strategy’s payoff and probability of success.

IP Group – Record exit underpinning the NAV

By Edison Investment Research

IP Group’s realisation activity has picked up notably in the months leading up to the company’s interim results publication in September, encouraging the company to increase the current buyback programme by £10m to £30m. Subsequently, IP Group agreed to sell the AI-powered financial crime detection business Featurespace to Visa. The exit will result in £134m in realisation proceeds at a 70% uplift to end-2023 carrying value, part of which was recognised in the H124 results, translating in a broadly stable value of IP Group’s private holdings. The de-rating of listed Oxford Nanopore (ONT) was therefore the major driver behind IP Group’s 9% NAV fall in total return (TR) terms in H124 to 104.7p, though nearly half of the ONT share price fall was reversed post end-June 2024, assisted by its half-year trading update and the Novo Holdings investment.


Bell Financial Group Ltd – Strong September quarter earnings drivers

By Research as a Service (RaaS)

  • RaaS has published an update report on diversified financials company Bell Financial Group (ASX:BFG) on the back of supportive September 2024 metrics including ECM league tables, ASX volumes and equity markets performance.
  • BFG is sitting fourth on the LSEG ECM league tables for the nine months to September 2024, raising $1.2b and on-track with RaaS forecasts (positive for Retail and Institutional).
  • The ASX200 closed 6.3% higher at the end of September 2024 relative to June 2024, above implied RaaS assumptions for the full-year and positive for the Portfolio Administration Services (PAS) business and overall investor confidence.ASX transaction volumes continue to recover from a weak CY23, up 32% for the September quarter and positive for the Retail and Technology & Platforms divisions.

Morning Views Asia: China Jinmao Holdings, Yuexiu Property

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars